Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.

European journal of haematology - 1 Oct 2014

Shimizu Hiroaki, Yokohama Akihiko, Hatsumi Nahoko, Takada Satoru, Handa Hiroshi, Sakura Toru, Nojima Yoshihisa

Abstract excerpt

Although the introduction of imatinib dramatically improved the outcomes for patients with Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia (Ph + BCP-ALL), the survival benefit of imatinib has not been assessed in the context of Ph + mixed phenotype acute leukemia (Ph + MPAL). To clarify this important issue, we studied 42 Ph+ acute leukemia (Ph + AL) patients who received intensive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to Benzamides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imatinib Mesylate

Share to Philadelphia Chromosome

Share to Piperazines

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Protein Kinase Inhibitors

Share to Pyrimidines

Source

Identifiers

PMID: 24750307
DOI: 10.1111/ejh.12343

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.PMID 24750307Read ↗

Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and/or bcr-abl positive in adultSemantic proximity Read ↗

Two Elderly Patients with Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia Who Were Successfully Treated with Dasatinib and Prednisolone.Semantic proximity Read ↗

Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.Semantic proximity Read ↗

Durable remission in a patient of mixed phenotype acute leukemia with Philadelphia chromosome-positive treated with nilotinib and lenalidomide: A case report.Semantic proximity Read ↗

Ph+ ALL: new approaches for upfront therapySemantic proximity Read ↗

Clinical and Molecular Characteristics of Patients with Mixed Phenotype Acute Leukemia.Semantic proximity Read ↗

How I treat mixed-phenotype acute leukemiaSemantic proximity Read ↗

[A study of mixed phenotype acute leukemia based on the 2008 World Health Organization classification].Semantic proximity Read ↗

Philadelphia Chromosome–Positive Acute Lymphocytic Leukemia: A New Era of ChallengesSemantic proximity Read ↗

Role of Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia in the Contemporary EraSemantic proximity Read ↗

[Diagnosis and treatment efficacy analysis of 29 children with mixed phenotype acute leukemia].Semantic proximity Read ↗

Clinical Characteristics and Diagnosis of Ph-Positive Mixed Phenotype Acute Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.